Achondroplasia is the most common skeletal dysplasia and is characterized by a variety of medical, functional and psychosocial challenges across the lifespan. There is variability in…
Despite the recognized expertise of pediatric endocrinologists, children with skeletal dysplasias have not been consistently managed by these physicians. Growth-altering treatments have broadened the role of…
Achondroplasia growth charts included in this article. Achondroplasia is the most common genetic skeletal disorder causing disproportionate short stature/dwarfism. Common additionalfeatures include spinal stenosis, midface retrusion,…
These treatment pathways were developed by the type 2 diabetes subgroup of the PES Diabetes SIG, using evidence base when available in combination with expert clinical…
Lipid management algorithms were developed by SIG members as a resource for use in clinical care and trainee education. Relevant guidelines were applied in the development…
The prevalence of obesity and associated comorbidities is rising. This material summarized the anti-obesity medications adapted by the PES Obesity Special Interest Group from the original…
This is a perspective that very briefly summarizes the evidence at that time of publication for treatment of youth-onset type 2 diabetes, as well as some…